Han; Sangdon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Han; Sangdon.The latest application filed is for "cannabinoid receptor modulators".

Company Profile

26.36.61

Han; Sangdon - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cannabinoid Receptor Modulators App 20220306586 - Jones; Robert M. ; et al.	2022-09-29
Somatostatin modulators and uses thereof Grant 11,414,397 - Zhao , et al. August 16, 2	2022-08-16
Cannabinoid Receptor Modulators App 20220241274 - Thatte; Jayant ; et al.	2022-08-04
Somatostatin Modulators And Uses Thereof App 20220048924 - Han; Sangdon ; et al.	2022-02-17
Cannabinoid receptor modulators Grant 11,214,548 - Jones , et al. January 4, 2	2022-01-04
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20210380560 - Blackburn; Anthony C. ; et al.	2021-12-09
Somatostatin modulators and uses thereof Grant 11,186,590 - Han , et al. November 30, 2	2021-11-30
Melanocortin Subtype-2 Receptor (mc2r) Antagonists And Uses Thereof App 20210238164 - HAN; Sangdon ; et al.	2021-08-05
Somatostatin modulators and uses thereof Grant 11,072,598 - Han , et al. July 27, 2	2021-07-27
Cannabinoid Receptor Modulators App 20210188781 - Jones; Robert M. ; et al.	2021-06-24
Somatostatin Modulators And Uses Thereof App 20210171492 - ZHAO; Jian ; et al.	2021-06-10
Somatostatin modulators and uses thereof Grant 11,028,068 - Zhao , et al. June 8, 2	2021-06-08
Crystalline forms and processes for the preparation of cannabinoid receptor modulators Grant 10,981,895 - Blackburn , et al. April 20, 2	2021-04-20
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Grant 10,981,894 - Han , et al. April 20, 2	2021-04-20
Cannabinoid Receptor Modulators App 20210060040 - Thatte; Jayant ; et al.	2021-03-04
Melanocortin Subtype-2 Receptor (mc2r) Antagonists And Uses Thereof App 20210002254 - HAN; Sangdon ; et al.	2021-01-07
SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20200407316 - Jones; Robert M. ; et al.	2020-12-31
Somatostatin Modulators And Uses Thereof App 20200283453 - Han; Sangdon ; et al.	2020-09-10
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Grant 10,766,877 - Han , et al. Sep	2020-09-08
Melanocortin Subtype-2 Receptor (mc2r) Antagonists And Uses Thereof App 20200216415 - HAN; Sangdon ; et al.	2020-07-09
Somatastatin Modulators And Uses Thereof App 20200207737 - ZHAO; Jian ; et al.	2020-07-02
Somatostatin modulators and uses thereof Grant 10,696,689 - Han , et al. June 30, 2	2020-06-30
Somatostatin Modulators And Uses Thereof App 20200190053 - ZHAO; Jian ; et al.	2020-06-18
Cannabinoid receptor modulators Grant 10,632,134 - Thatte , et al.	2020-04-28
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Grant 10,604,507 - Han , et al.	2020-03-31
Somatostatin Modulators And Uses Thereof App 20200087318 - HAN; Sangdon ; et al.	2020-03-19
Cannabinoid Receptor Modulators App 20200069681 - Thatte; Jayant ; et al.	2020-03-05
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Grant 10,562,884 - Han , et al. Feb	2020-02-18
Cannabinoid Receptor Modulators App 20200017448 - Jones; Robert M. ; et al.	2020-01-16
Somatostatin Modulators And Uses Thereof App 20200010453 - HAN; Sangdon ; et al.	2020-01-09
Melanocortin Subtype-2 Receptor (mc2r) Antagonists And Uses Thereof App 20200010452 - HAN; Sangdon ; et al.	2020-01-09
Somatostatin Modulators And Uses Thereof App 20190382367 - ZHAO; Jian ; et al.	2019-12-19
Melanocortin Subtype-2 Receptor (mc2r) Antagonists And Uses Thereof App 20190367481 - HAN; Sangdon ; et al.	2019-12-05
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20190308952 - Blackburn; Anthony C. ; et al.	2019-10-10
Somatostatin modulators and uses thereof Grant 10,351,547 - Zhao , et al. July 16, 2	2019-07-16
SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20190135752 - Jones; Robert M. ; et al.	2019-05-09
Primary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20190070149 - Teegarden; Bradley ; et al.	2019-03-07
Crystalline forms and processes for the preparation of cannabinoid receptor modulators Grant 10,183,930 - Blackburn , et al. Ja	2019-01-22
Somatostatin Modulators And Uses Thereof App 20190002431 - ZHAO; Jian ; et al.	2019-01-03
Cannabinoid Receptor Modulators App 20180354907 - Jones; Robert M. ; et al.	2018-12-13
Cannabinoid Receptor Modulators App 20180280386 - Thatte; Jayant ; et al.	2018-10-04
Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Grant 9,987,252 - Teegarden , et al. June 5, 2	2018-06-05
Cannabinoid receptor modulators Grant 9,944,606 - Jones , et al. April 17, 2	2018-04-17
Somatostatin modulators and uses thereof Grant 9,902,703 - Zhao , et al. February 27, 2	2018-02-27
Somatostatin modulators and uses thereof Grant 9,896,432 - Zhao , et al. February 20, 2	2018-02-20
Somatostatin Modulators And Uses Thereof App 20180016252 - ZHAO; Jian ; et al.	2018-01-18
Cannabinoid receptor modulators Grant 9,867,822 - Thatte , et al. January 16, 2	2018-01-16
Cannabinoid Receptor Modulators App 20170304327 - Thatte; Jayant ; et al.	2017-10-26
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20170217885 - Jones; Robert M. ; et al.	2017-08-03
Primary Amines And Derivitves Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20170189381 - Teegarden; Bradley ; et al.	2017-07-06
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20170144993 - Blackburn; Anthony C. ; et al.	2017-05-25
Cannabinoid Receptor Modulators App 20170143704 - Thatte; Jayant ; et al.	2017-05-25
Cannabinoid receptor modulators Grant 9,597,340 - Thatte , et al. March 21, 2	2017-03-21
Somatostatin Modulators And Uses Thereof App 20170001966 - ZHAO; Jian ; et al.	2017-01-05
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Grant 9,522,133 - Jones , et al. December 20, 2	2016-12-20
Cannabinoid receptor modulators Grant 9,492,447 - Thatte , et al. November 15, 2	2016-11-15
Crystalline forms and processes for the preparation of cannabinoid receptor modulators Grant 9,458,136 - Blackburn , et al. October 4, 2	2016-10-04
Cannabinoid Receptor Modulators App 20160271127 - Thatte; Jayant ; et al.	2016-09-22
Primary amines and derivatives thereof as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto Grant 9,328,107 - Teegarden , et al. May 3, 2	2016-05-03
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20150335618 - Jones; Robert M. ; et al.	2015-11-26
Primary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20150265576 - Teegarden; Bradley ; et al.	2015-09-24
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Grant 9,126,932 - Jones , et al. September 8, 2	2015-09-08
Cannabinoid Receptor Modulators App 20150126477 - Thatte; Jayant ; et al.	2015-05-07
Primary amines and derivatives thereof as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto Grant RE45,336 - Teegarden , et al. January 13, 2	2015-01-13
Primary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20140235622 - Teegarden; Bradley ; et al.	2014-08-21
Cannabinoid Receptor Modulators App 20140206649 - Thatte; Jayant ; et al.	2014-07-24
Cannabinoid receptor modulators Grant 8,778,950 - Jones , et al. July 15, 2	2014-07-15
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20140135345 - Blackburn; Anthony C. ; et al.	2014-05-15
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto App 20140066369 - Jones; Robert M. ; et al.	2014-03-06
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Grant 8,664,258 - Teegarden , et al. March 4, 2	2014-03-04
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20140038987 - Jones; Robert M. ; et al.	2014-02-06
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto App 20140018371 - Jones; Robert M. ; et al.	2014-01-16
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Grant 8,580,841 - Jones , et al. November 12, 2	2013-11-12
Cannabinoid Receptor Modulators App 20130165412 - Jones; Robert M. ; et al.	2013-06-27
Modulators Of The Gpr119 Receptor And The Treatment Of Disorders Related Thereto App 20130023494 - Jones; Robert M. ; et al.	2013-01-24
Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20120270861 - TEEGARDEN; BRADLEY ; et al.	2012-10-25
Cannabinoid Receptor Modulators App 20120214766 - Jones; Robert M. ; et al.	2012-08-23
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Grant 8,148,417 - Teegarden , et al. April 3, 2	2012-04-03
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic Acid Derivatives Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20110130409 - Jones; Robert M. ; et al.	2011-06-02
Primary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20090197935 - Teegarden; Bradley ; et al.	2009-08-06
1,2-Dihydro-Spiro[3H-Indole-3,4'-Piperidine] Compounds, as Modulators of the Mas Receptor Novel App 20080200491 - Tran; Thuy-Anh ; et al.	2008-08-21
Novel quinazoline derivatives and methods of treatment related to the use thereof App 20070010671 - Sekiguchi; Yoshinori ; et al.	2007-01-11
Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof App 20050197350 - Sekiguchi, Yoshinori ; et al.	2005-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.